CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6,000 | $11,000 | $9,000 | $88,600 | $87,754 |
| Cost of revenue | $2,194 | $4,400 | $3,600 | $28,491 | $47,949 |
| Gross profit | $3,806 | $6,600 | $5,400 | $60,109 | $39,805 |
| Selling, general & administrative | $3.8M | $3.2M | $3.6M | $3.9M | $3.0M |
| Research and development | $2.3M | $2.4M | $2.0M | $6.3M | $109,180 |
| Operating expenses | $6.1M | $5.8M | $5.6M | $10.3M | $3.2M |
| Operating income | -$6.1M | -$5.7M | -$5.6M | -$10.2M | -$3.1M |
| Interest expense | — | — | — | $0 | $4.3M |
| Pretax income | -$6.0M | -$5.5M | -$5.3M | -$10.1M | $19.2M |
| Income tax expense | $0 | $0 | $0 | $0 | $0 |
| Net income | -$6.0M | -$5.5M | -$5.3M | -$10.1M | $19.2M |
| Balance Sheet | |||||
| Cash and equivalents | — | — | — | — | $10.7M |
| Current assets | $7.4M | $6.1M | $10.3M | $18.7M | $10.7M |
| Total assets | $7.8M | $6.7M | $10.7M | $19.2M | $11.3M |
| Current liabilities | $284,880 | $327,644 | $371,394 | $3.3M | $1.1M |
| Total liabilities | $284,880 | $327,644 | $371,394 | $3.3M | $1.1M |
| Stockholders' equity | $7.5M | $6.3M | $10.3M | $15.9M | $10.2M |
| Cash Flow Statement | |||||
| Cash from operations | -$5.9M | -$5.3M | -$8.0M | -$7.8M | -$2.2M |
| Depreciation and amortization | — | $56,000 | $56,000 | — | — |
| Stock-based compensation | $3,485 | $36,648 | $36,648 | $68,746 | $595,380 |
| Share repurchases | $10,000 | $174,964 | $270,952 | $0 | — |
Shares outstanding 3.7M · Free float 98.7%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.